BFSG LLC’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-300
Closed -$30.5K 759
2025
Q4
$30.5K Hold
300
﹤0.01% 445
2025
Q3
$16.4K Hold
300
﹤0.01% 497
2025
Q2
$15.9K Hold
300
﹤0.01% 473
2025
Q1
$13K Hold
300
﹤0.01% 479
2024
Q4
$16.9K Hold
300
﹤0.01% 458
2024
Q3
$20.4K Hold
300
﹤0.01% 446
2024
Q2
$12.7K Hold
300
﹤0.01% 455
2024
Q1
$20.7K Hold
300
﹤0.01% 443
2023
Q4
$22.2K Buy
+300
New +$19.7K ﹤0.01% 408
2019
Q3
Sell
-5,121
Closed -$604K 188
2019
Q2
$604K Sell
5,121
-198
-4% -$19.9K 0.24% 77
2019
Q1
$461K Buy
+5,319
New +$453K 0.17% 106

Other funds holding EXAS

BFSG LLC's EXAS Position: Q1 2026 in Review

BFSG LLC sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 300 shares — an estimated $30.5K sold.

BFSG LLC first reported a position in EXAS in Q1 2019 and held it in 11 quarters. The position peaked at $604K in Q2 2019. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • BFSG LLC reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • BFSG LLC sold 300 Exact Sciences shares in Q1 2026, an estimated $30.5K.
  • BFSG LLC first reported a position in Exact Sciences in Q1 2019 and held it in 11 quarters.
  • BFSG LLC's Exact Sciences position peaked at $604K in Q2 2019.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on BFSG LLC's 13F filing for Q1 2026, filed 29 Apr 2026.